Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
4,241 | Dovepress* | 3,354 | 553+ | 1,155 | 3,907 |
PubMed Central* | 0 | 334 | 137 | 334 | |
Totals | 3,354 | 887 | 1,292 | 4,241 | |
*Since 19 September 2018 +Since July 2016 |
View citations on PubMed Central and Google Scholar